Zhao L, Xue S, Chen F, Stan H. Inflammation, Atherosclerosis and Cardiovascular and Cerebrovascular Diseases. Adv Cardiovasc Dis. 2005;26:193-196.
 Bora K, Pathak M S, Borah P, Hussain MI, Das D. Association of the Apolipoprotein A-I Gene Polymorphisms with Cardiovascular Disease Risk Factors and Atherogenic Indices in Patients from Assam, Northeast India. Balkan J Med Genet. 2017;20:59-70.
 Cui XM. Study on hyperlipidemia status of a district departments staff in Tianjin City. Journal of Qiqihar Medical University. 2016;37:2580-2581.
 Zeng Q, Xie Y, Wang JS. Epidemiological status of cardiovascular and cerebrovascular diseases in population of Yangzhou City in Jiangsu Province. Journal of Clinical Medicine in Practice. 2019;23:37-40.
 Ou HJ. The relationship of APOA5/A4/C3/A1 gene cluster and APOB gene polymorphisms With Dyslipidemia [D].Shihezi city: Shihezi University; 2014.
 Meng Q, Zhang XH, Zhang XW. Meta-anaylsis on association of ApoE gene polymorphism with hyperlipidemia. Chinese Preventive Medicine. 2015;16:304-307.
 Feng DW. Association between Polymorphisms of APOA1 Gene and Susceptibility for Uyghur and Kazak’s Dyslipidemia [D]. Shihezi city: Shihezi University; 2016.
 Han Y. Association between the Subclasses of HDL and APOA5 Gene Polymorphism in Hypertriglyceridemia[D]. Hengyang city: University of South China; 2012.
 Zhang PZ, Tian Y. Relationship of Apolipoprotein B and E Gene Polymorphisms to Dyslipidemia and the Influence of Exercise Training. China Sport Science. 2006;26:65-69.
 Zhang Y, Zeng T, Xu J, Liu L. Apolipoprotein Gene Polymorphism in Coronary Heart Disease. Adv Cardiovasc Dis. 2019;40:1294-1297.
 Chinese Joint Committee for revision of guidelines for Prevention and treatment of Adult Dyslipidemia. Guidelines for the prevention and treatment of dyslipidemia in Chinese adults (revised in 2016). Chinese Circulation Journal. 2017;32:53.
 WELLS G A. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses: Symposium on Systematic Reviews: Beyond the Basics, 2000.
 Zhao QR, Lei YY, Li J, Jiang N, Shi JP. Association between apolipoprotein E polymorphisms and premature coronary artery disease: a meta-analysis. Clin Chem Lab Med. 2017,55:284-298.
 Zhao DD. Relationship between apolipoprotein A5, C3 and E gene polymorphisms and phlegm and blood stasis syndrome and therapeutic effect in patients with hyperlipidemia [D]. Beijing: China Academy of Chinese Medical Sciences; 2007.
 Niu ZB. Association study between lipid metabolism-related genepolymorphisms and polymorphisms and hyperlipidemia in aged patients withlong-term aerobic exercise[D]. Shanghai: Shanghai University of Sport; 2016.
 Huang MC, Wang TN, Wang HS, Sung YC, Ko YC, Chiang HC. The -1131T>C polymorphism in the apolipoprotein A5 gene is related to hypertriglyceridemia in Taiwanese aborigines. Kaohsiung J Med Sci. 2008;24:171-179.
 Long SY, Chen ZJ, Han Y, Christopher DM, Zhang CP, Yang Y, et al. Relationship between the distribution of plasma HDL subclasses and the polymorphisms of APOA5 in hypertriglyceridemia. Clin Biochem. 2013;46:733-739.
 Di Taranto MD, Staiano A, D'Agostino MN, D'Angelo A, Bloise E, Morgante A, et al. Association of USF1 and APOA5 polymorphisms with familial combined hyperlipidemia in an Italian population. Mol Cell Probes. 2015;29:19-24.
 Ferreira CN, Carvalho MG, Fernandes AP, Santos IR, Rodrigues KF, Lana AMQ, et al. The polymorphism -1131T>C in apolipoprotein A5 gene is associated with dyslipidemia in Brazilian subjects. Gene. 2013;516:171-175.
 Brito DD, Fernandes AP, Gomes KB, Coelho FF, Cruz NG, Sabino AP, et al. Apolipoprotein A5-1131T>C polymorphism, but not APOE genotypes, increases susceptibility for dyslipidemia in children and adolescents. Mol Biol Rep. 2011;38:4381-4388.
 Liu ZK, Hu M, Baum L, Thomas GN, Tomlinson B. Associations of polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese. Atherosclerosis. 2010;208:427-432.
 Henneman P, van der Sman-de Beer F, Moghaddam PH, Huijts P, Stalenhoef AFH, Kastelein JJP, et al. The expression of type III hyperlipoproteinemia: involvement of lipolysis genes. Eur J Hum Genet. 2009;17:620-628.
 Huang G, Zhong H, Re HM, Mao HM, Chi YH. Association of polymorphisms of apoB genes EcoRI, XbaI, and MspI and apoAI gene - 75 bp and + 83 bp with dyslipidemia in Kazaks. The Journal of Practical Medicine. 2011;27:3518-3522.
 Chi YH. Relationship between ApoB gene EcoRI, XbaI, MspI and apoAI gene-75bp, + 83bp polymorphisms and blood lipids [D]. Shihezi city: Shihezi University; 2012.
 Xie YJ. The Association of APoB and APoAI Gene Polymorphism With DysliPidemia in Han Chinese of Xinjiang Shihezi [D]. Shihezi city: Shihezi University; 2011.
 Zhu H, Liu Y, Bai H, Liu BW. Apolipoprotein AⅠ Gene MspI Polymorphism in Relation to Endogenous Hypertriglyceridemia in Chinese Population. Chin J Arterioscler. 2001;9:332-336.
 Jia LQ, Bai H, Fu MD, Xu YH, Gou LT. Relationship of subclasses of serum HDL and Apo A-Ⅰ gene polymorphism in hyperlipidemia. Chinese Journal of Pathophysiology. 2006(04):796-800.
 Cao WJ, Sheng L, Yang J, Zhou D, Cheng J. Relationship between MspI polymorphism of apolipoprotein B gene and blood-fat of Hazakh inhabitant. Journal of Practical Medical Techniques. 2009.16:770-772.
 Chi YH, Huang G, Xie YJ, Guo ZL. Study on relationship between joint action of EcoR I, Xba I and Msp I polymorphisms of apoB gene and dyslipidemia. Journal of Clinical and Experimental Medicine. 2012;11:481-483.
 Jin YN, Zhou L, Tang M, Zhang MJ, Tang XJ. Relationship between ApoB gene Msp Ⅰ/Xba Ⅰ/EcoR Ⅰ polymorphisms and serum lipid level in male Han population in Chongqing,China. Academic Journal of Second Military Medical University. 2015;36:966-971.
 Cavalli SA, Hirata MH, Salazar LA, Diament J, Forti N, Giannini SD, et al. Apolipoprotein B gene polymorphisms: prevalence and impact on serum lipid concentrations in hypercholesterolemic individuals from Brazil. Clin Chim Acta. 2000;302:189-203.
 Qian J, Hu DC, Zhao XL, Shao JC. Study on relationship between apolipoprotein B gene polymorphisms frequencies distributionand and essential hyperlipidemia of an nationality in Kunming area. Int J Lab Med. 2010;31:1262-1264.
 Feng JS, Xie XQ, Lin CL. Apolipoprotein B Gene Polymorphisms in Patients with Hyperlipidemia or Coronary Heart Disease. Journal of Jinan University (Natural Science & Medicine Edition). 1997;18:14-18.
 Ma ZZ, Huang WB, He FP, Zhang SB. Relationship between apolipoprotein B gene polymorphisms and lipid levels in Yao population of Yuebei area. J Mol Diagn Ther. 2012;4:333-335.
 Zhang PZ, Tian Y. Influence of Apolipoprotein B Gene Polymorphisms over Effect of Exercise on Blood Lipid. China Sport Science. 2015;35:38-47.
 Talmud PJ, Barni N, Kessling AM, Carlsson P, Darnfors C, Bjursell G, et al. Apolipoprotein B gene variants are involved in the determination of serum cholesterol levels: a study in normo- and hypelipidaemic individuals. Atherosclerosis. 1987;67:81-9.
 Gong LG, Liu XR, Qiu GB, Li HF, Cui XW. Analysis of XbaI polymorphism in the ApoB gene to hypertriglyceridemics in Chinese population. Chin J Lab Diagn. 2003;7:306-308.
 Choong ML, Sethi SK, Koay ES. Effects of intragenic variability at 3 polymorphic sites of the apolipoprotein B gene on serum lipids and lipoproteins in a multiethnic Asian population. Hum Biol. 1999;71:381-397.
 Timirci O, Darendeliler F, Bas F, Arzu EH, Umit Z, Isbir T. Comparison of lipid profiles in relation to APOB EcoRI polymorphism in obese children with hyperlipidemia. In Vivo. 2010;24:65-69.
 Liang JP, Yang HM, Sheng T, Han LB, Yuan YJ, Niu XH, et al. Study on the relationship between ApoE gene polymorphism and plasma lipid levels of phlegm-blood-stasis syndrome of hyperlipemia. China Journal of Traditional Chinese Medicine and Pharmacy. 2008;23:633-635.
 Wu XH, Cheng J, Zhou ZZ, Qin JM, He L. Relationship between apolipoprotein E gene polymorphism and blood lipids in Kazakh population in Xinjiang. Chinese Journal of Clinical Laboratory Science. 2007;25:447-449.
 Hu HN, Chen W, Yang G, Lv M. Association of polymorphisms of apoprotein E and lipid levels with hyperlipidemia. Chinese Journal of Tissue Engineering Research. 2007;11:1453-1456.
 Zeng ZW, Peng S, Peng J, Gong WX. Relationship between apolipoprotein E gene polymorphism and hyperlipidemia. Guangdong Medical Journal. 2001;22:120-121.
 Zeng WW, Lv XY, Chen BS. The Study on the Association between PolymorPhism of APoliPoProtein E Gene and HyPerliPidemia. Chin J Arterioscler. 1996;4:185-189.
 Wang R, Xie RL, Huang WF, Yang MQ. Apolipoprotein E gene polymorphism and its relationship with type Ⅳ hyperlipidemia. Sichuan Medical Journal. 2005;26:400-401.
 Zhu CL, Zhou X, Liu F, Hu HL. The Relationship Between Polymorphisms of Apolipoprotein E Gene and Serum Lipid. Chinese Journal of Arteriosclerosis. 2005;13:203-206.
 Tian Y, Long SY, Xu YH, Fu MD, Zhang XM, Liu BW. Study on apoE gene polymorphism and subclasses of serum high density lipoprotein in type Ⅳ hyperlipidemia. Chin J Med Genet. 2005;22:100-102.
 Zhang YH, Dou XF, Shang W, Dou XF, Wang YF, Liu YQ, et al. Association Between Familial Combined Hyperlipidemia (FCHL) and Apolipoprotein E Polymorphism. Chinese Journal of Hypertension. 2004;22:29-32.
 Jiang WM, Fang ZY, Zhu CL, Tang SH. Effects of ApoE Gene Polymorphism on Anti-inflammatory Action of Xuezhikang Capsule. Chinese Journal of Integrated Traditional and Western Medicine. 2013;33:35-39.
 Qian J, Jiang WM, Chen XH, Zhu CL, Xie L. Study on the Relation between ApoE Gene Polymorphisms and the Plasma Lipids in Hyperlipemia Patients. Chinese General Practice. 2011;14:840-842.
 Liu YL, Li JK, Yan ZQ, Chen YJ. Correlation between apolipoprotein E gene polymorphism and plasma lipid level. J Fourth Mil Med Univ. 2006;27:460-461.
 Zhan CY. Study on the relationship between Apolipoprotein E Gene Polymorphism and Blood Lipid level and Lipid-regulating effect in Hyperlipidemia with phlegm and Blood stasis Syndrome[D]. Beijing: Beijing University of Chinese Medicine; 2006.
 Luo R, Chen WY. Relationship between apolipoprotein E gene polymorphism and hyperlipidemia. Chinese Journal of Coal Industry Medicine. 2006;9:246-247.
 Zhang XM, Bai H, Liu BW, Fan P, Zhang RJ, Xu YH, et al. Study on apoE Gene Polymorphism in Chinese Type Ⅱb Hyperlipidemia. Journal of Sichuan University (Medical Science Edition). 2001;32:179-182.
 Jiang WM, Chen XH, Tang SH, Zhu CL, Xie L. Relationship between TCM syndrome differentiation and ApoE exon 4 polymorphism and dyslipidemia in patients with hyperlipidemia complicated with hypertension. The third National Youth Forum on Cardiovascular Diseases with Integrated traditional Chinese and Western Medicine and the second Symposium of Cardiovascular Committee of Xinjiang Society of Integrated traditional Chinese and Western Medicine; 2013 Sep 20; Urumqi, Xinjiang, China. Xinjiang (China): The third National Youth Forum on Cardiovascular Diseases with Integrated traditional Chinese and Western Medicine and the second Symposium of Cardiovascular Committee of Xinjiang Society of Integrated traditional Chinese and Western Medicine; 2004.p. 172-177. Chinese
 Jiang WM, Zhu CL, Liu J, Tang SH. Correlation analysis of TCM syndrome characteristics with ApoE gene polymorphisms in 212 hyperlipemia patients. China Journal of Traditional Chinese Medicine and Pharmacy, 2012;27:1458-1460.
 Long SY, Zhang XM, Fu MD, Xu YH, Liu BW. Relationship of APOE gene polymorphism with subclasses of serum high density lipoprotein in hyperlipidemia. Chin J Med Genet. 2004;21:83-86.
 Zhang XM, Liu BW, Bai H, Fan P. Study on apoE gene polymorphism in Chinese endogenous hypertriglycerdemia. Chin J Med Genet. 2001;18:21-25.
 Wiegman A, Sijbrands EJG, Rodenburg J, Defesche JC, de Jongh S, Bakker HD, et al. The apolipoprotein epsilon4 allele confers additional risk in children with familial hypercholesterolemia. Pediatr Res. 2003;53:1008-1012.
 Alharbi TH, Batais MA, Hasanato RM, Alharbi FK, Khan IA, Alharbi KK. Role of Apolipoprotein E gene polymorphism in the risk o f familial hypercholesterolemia: a case-control study. Acta Biochim Pol. 2018;65:415-420.
 Corella D, Guillén M, Portolés O, Sabater A, Cortina S, Folch J, et al. Apolipoprotein E gene polymorphism and risk of hypercholesterolemia: a case control study in a working population of Valencia. Med Clin. 2000;115:170-175.
 Kobori S, Nakamura N, Uzawa H, Shichiri M. Influence of apolipoprotein E polymorphism on plasma lipid and apolipoprotein levels, and clinical characteristics of type III hyperlipoproteinemia due to apolipoprotein E phenotype E2/2 in Japan. Atherosclerosis. 1988;69:81-8.
 Cenarro A, Etxebarria A, de Castro-Orós I, Stef M, Bea AM, Palacios L, et al. The p.Leu167del Mutation in APOE Gene Causes Autosomal Dominant Hypercholesterolemia by Down-regulation of LDL Receptor Expression in Hepatocytes. J Clin Endocrinol Metab. 2016;101:2113-2121.
 Meena K, Misra A, Vikram N, Ali S, Pandey RM,Luthra K. Cholesterol ester transfer protein and apolipoprotein E gene polymorphisms in hyperlipidemic Asian Indians in North India. Mol Cell Biochem. 2011;352:189-196.
 Solanas-Barca M, de Castro-Orós I, Mateo-Gallego R, Cofán M, Plana N, Puzo J, et al. Apolipoprotein E gene mutations in subjects with mixed hyperlipidemia and a clinical diagnosis of familial combined hyperlipidemia. Atherosclerosis. 2012;222:449-55.
 Ferreira CN, Carvalho MG, Fernandes APSM, Lima LM, Loures-Valle AA, Dantas J, et al. Comparative study of apolipoprotein-E polymorphism and plasma lipid levels in dyslipidemic and asymptomatic subjects, and their implication in cardio/cerebro-vascular disorders. Neurochem Int. 2010;56:177-182.
 Fumeron F, Rigaud D, Bertiere MC, Bardon S, Dely C, Apfelbaum M. Association of apolipoprotein epsilon 4 allele with hypertriglyceridemia in obesity. Clin Genet. 1988;34:258-264.
 Kuusi T, Taskinen M R, Solakivi T, Kauppinen-Mäkelin R. Role of apolipoproteins E and C in type V hyperlipoproteinemia. J Lipid Res. 1988;29:293.
 Hou YH, Nie B, Shen XX. ApoE-knockout Mice for Study of Atherosclerosis. Adv Cardiovasc Dis. 2017;38:679-683.
 Zhao SP. Apolipoprotein E Polymorphism and Blood Lipid Metabolism and its Clinical Significance. Journal of Clinical and Pathological Research. 1994;14:231-233.
 Chen YD, Zhao X, Tan YQ, Rao SQ. A Meta-analysis of the Association Apo B Eco RI Polymorphism and Coronary Heart Disease in Chinese Population. Chin J Arterioscler. 2015;23:1056-1060.
 Benn M, Nordestgaard BG, Jensen JS, Grande P, Sillesen H, Tybjaerg-Hansen A. Polymorphism in APOB associated with increased low-density lipoprotein levels in both genders in the general population. J Clin Endocrinol Metab. 2005;90:5797-5803.
 Zhang S, Guo Y, Ma Y. Meta-analysis on relationship between ApoB gene XbaI polymorphism and cerebral infarction in Chinese population. Journal of Clinical Neurology. 2007;20:423-425.
 Renges HH, Wile DB, McKeigue PM, Marmot MG, Humphries SE. Apolipoprotein B gene polymorphisms are associated with lipid levels in men of South Asian descent. Atherosclerosis. 1991;91:267-275.
 Song WW, Hu RM, Luo BY. Study on angiopathy and metabolic disorder of serum TC, LDL-C and Apo-B in patients with type 2 diabetes mellitu. Chin J Endocrinol Metab. 1998;14:71-72.
 Li Q. The association of -75bp/ +83bp polymorphism of the Apo A1Apo A11 gene with dyslipidemia [D]. Dalian city: Dalian Medical Universit; 2009.
 Wu MM, Wang H, Yang LJ, Han TT, Sun X, Xiao S. Relationship between apolipoprotein A5, apolipoprotein C3 and coronary heart disease. Clinical Focus. 2019;34:477-480.
 Chang J. Effect between Apolipoprotein A5 and the metabolism of serum and related disease[D]. Jinan city: Shandong University; 2006.
 Kim M, Kim M, Yoo HY, Lee E, Chae JS, Lee SH, et al. A promoter variant of the APOA5 gene increases atherogenic LDL levels and arterial stiffness in hypertriglyceridemic patients. PloS one. 2017;12:e186693.
 Zhai GH, Ma JL, Li MF. Association between apolipoprotein A5-1131T/C polymorphism and type 2 diabetes mellitus in Chinese Han population:A meta-analysis. Int J Lab Med. 2019;40:1321-1324.